RxDoctor Payments Data

Li-Mei Lin

Neurological Surgery · Tucson, AZNPI 1538296785

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $521,970 of the $652,508 with a category attached, or 80.0%. Stryker accounts for 89.4% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2020 at $225,735 and has fallen 100.0% since, to $40 in 2025. Among neurological surgery clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$652,508in general payments, 2019–2025

Across 911 payments — averaging $716.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$583K
  • Balt USA, LLC$24K
  • Rapid Medical Ltd$17K
  • Medtronic$13K
  • Depuy Synthes Products, Inc.$7K
  • Microvention, Inc.$4K
  • plus $4K from 9 others
$21,339in research payments, 2019–2025

Across 10 payments — averaging $2133.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$18K
  • Rapid Medical Ltd$2K
  • Stryker$859

What the payments were for

  • Consulting fees$521,97080%
  • Speaking & faculty fees$28,9494%
  • Travel & lodging$83,86813%
  • Food & beverage$17,7213%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$652,508 in reported general payments places this provider in the 90th percentile of 173 neurological surgery providers in Arizona.

See all neurological surgery providers in Arizona

Most prescribed under Part D

DrugClaimsCost to plans & patients
BrilintaTicagrelor11$7,675

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBrilinta$125$7,67511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 173 neurological surgery providers in Arizona.

Other neurological surgery in Tucson

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →